Delivery Order SPE2DB22D9304-SPE2DB24FSSY9

Award Date 7/18/24
Potential Completion Date 8/8/24
Potential Value $49K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,449.30 contract is for the delivery of Entyvio 300 mg vials, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the DLA to issue firm fixed-price delivery...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The delivery order, valued at $48,122.60, is for the supply of 300 mg Entyvio vials, a specialty medication used to treat certain gastrointestinal conditions. The delivery order is part of a larger $499,999,999 Indefinite Delivery Contract (IDC) held by DMS Pharmaceutical Group with the...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $189,476.40 contract is for the delivery of Entyvio 300 mg vials, a specialty biologic medication, to support the recurring medical supply needs of military health facilities worldwide. The contract is issued under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $71,053.65, is for the delivery of Entyvio 300 mg vials, a pharmaceutical product. The award is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the SPE2DB program. This single-award IDC allows the...
This is a $49,286.80 firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The order is for Entyvio 300 mg vials, a biologic medication used to treat certain gastrointestinal conditions. The delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group with the DLA under the Medical Supply Chain...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $59,144.16, is for the delivery of Entyvio 300 mg vials, a specialty biologic medication, to support the recurring medical supply needs of military health facilities. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA,...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $59,144.16, is for the delivery of Entyvio 300 mg vials, a biologic medication, to support the recurring medical supply needs of military health facilities worldwide. DMS Pharmaceutical Group holds a large indefinite delivery contract (IDC) with the DLA under...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $14,210.70 award is for the supply of Entyvio 300 mg vials, a biologic medication used to treat certain gastrointestinal conditions. The delivery order was placed under DMS Pharmaceutical Group's $499,999,999 indefinite delivery contract (IDC) with the DLA, which allows the agency to issue orders for a broad...
This is a firm fixed-price delivery order award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The $92,666.80 order is for Entyvio 300 mg vials, a specialized pharmaceutical product. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program to provide a wide range of branded and generic prescription drugs, over-the-counter medications, biologics, and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $24,643.40, is for the delivery of Entyvio 300 mg vials to support the recurring medical supply needs of military health facilities worldwide. The contract is part of DMS Pharmaceutical Group's larger indefinite delivery contract (IDC) with the DLA under...
  • SPE2DB22D9304
    Indefinite Delivery Contract
  • SPE2DB22D9304-SPE2DB24FSSY9
    Delivery Order

This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $49,286.80 contract is for the supply of Entyvio 300 mg vials, a specialty medication used to treat certain gastrointestinal conditions.

The delivery order is part of a larger, single-award indefinite delivery contract (IDC) valued up to $499,999,999 that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This IDC allows the DLA to issue firm fixed-price delivery orders to DMS for a comprehensive range of pharmaceutical items to support the recurring medical supply needs of military health facilities worldwide. There is no set-aside designation for this particular delivery order.

Through this contract vehicle and other prime vendor agreements, DMS Pharmaceutical Group provides both routine and critical medications, including branded and generic prescription drugs, biologics, and medical consumables, to fulfill the diverse medical requirements of the Department of Defense and Department of Veterans Affairs healthcare systems across the globe.

Generated 10/17/24, 9:43 AM